antifungal agent 1

Antifungal agent 1 is an effective antifungal agent.

Antifungal agent 100 (compound 3i) demonstrates notable antifungal activity, exhibiting an EC 50 of 0.33 mg L against S. sclerotiorum. It also possesses an IC 50 value of 0.63 mg mL targeting the Succinate dehydrogenase (SDH) of the same organism [1].

Antifungalagent 109 (compound F) is a spirorings [thiazolidinone] compound with antifungal properties, exhibiting inhibition zones of 10-17 mm.

Antifungal agent 114 (Compound 19g) serves as an inhibitor of Cytochrome P450 (Cytochrome P450), effectively suppressing CYP2C9, CYP2C19, CYP2D6, and CYP3A4 at 10 μM. It exhibits antifungal activity against Cryptococcus neoformans, Candida, and Aspergillus, with an MIC of less than 0.0625 μg mL. Additionally, Antifungal agent 114 demonstrates favorable metabolic stability in human liver microsomes with a half-life of 107 minutes.

Antifungalagent 117 is a bipyrrole carboxamide derivative with antifungal activity, exhibiting an EC50 value of 11.58 mg L against Sclerotinia sclerotiorum. This compound induces cell death by increasing cell membrane permeability, causing an imbalance in osmotic pressure between the interior and exterior of the cell. It also promotes oxidative damage to the cell membrane by inducing the accumulation of reactive oxygen species (ROS), leading to the leakage of cellular contents. RNA sequencing analysis has demonstrated that Antifungalagent 117 disrupts cell membrane structure by downregulating catalase genes and upregulating neutral ceramidase genes, accelerating ceramide metabolism and hastening cell death. The compound holds significant potential for application in plant protection and the control of fungal infections.

Antifungalagent 112 (Compound 1e) exhibits antifungal activity against Candida albicans, Aspergillus niger, and Aspergillus fumigatus, with minimum inhibitory concentrations (MIC) of 0.0024 M, 0.0022 M, and 0.0028 M, respectively.

Antifungalagent 110 exhibits antifungal activity against Botrytis cinerea and Rhizoctonia solani. It demonstrates significant effectiveness in inhibiting R. solani, with an EC50 value of 0.27 mg L. Antifungalagent 110 shows promise for use in plant disease research.

Antifungalagent 116 (compound 1a) exhibits broad-spectrum antifungal (fungal) activity.

Antifungalagent 115 (compound 8n) is a non-competitive inhibitor of chitin synthase (CHS), displaying an IC50 of 93 µM. It exhibits both broad-spectrum antifungal activity and significant efficacy against resistant fungi. Antifungalagent 115 is useful for studies on fungal infections.

Antifungalagent 118 (compound C22) inhibits the mycelial growth of V. mali by inducing oxidative damage and compromises the integrity of the cell membrane.

Antifungalagent 122 (compound 201), a potent and broad-spectrum antifungal agent, prevents the phase shift in fungi and the formation of fungal biofilms. This compound effectively inhibits the enzymatic activity of CYP3A4-M and CYP3A4-T, with IC50 values of 2.11 and 4.53 µM, respectively. Notably, Antifungalagent 122 exhibits no cytotoxicity.

Antifungal Agent 121 (compound TM11) is a fungicide characterized chemically as a benzimidazole-acrylonitrile derivative.

Antifungalagent 113 (compound 9a) serves as an effective antifungal and antibacterial agent. It exhibits strong inhibitory activity against both S. aureus and methicillin-resistant S. aureus.

Antifungalagent 123 (Compound 4b) demonstrates strong affinity for the oxidoreductase of Staphylococcus aureus or membrane proteins of Candida albicans, exhibiting both antibacterial and antifungal properties. Additionally, it is capable of scavenging free radicals, showcasing antioxidant effects. Antifungalagent 123 also inhibits the TLR signaling pathway and possesses anti-inflammatory activity.

Antifungalagent 125 (compound 4H) is a potent succinate dehydrogenase (SDH) inhibitor with an IC50 of 3.59 μg mL and exhibits fungicidal activity against Alternaria alternata.

Antifungalagent 257 (Compound 7e) is a broad-spectrum antifungal agent with an EC50 value of 4.15 μM against F. graminearum.

Antifungal agent 18 is a new antifungal compound used for treating fungal infections.

Antifungal agent 15 exhibits remarkable potency, with EC50 values of 0.52 and 0.50 μg mL against S. sclerotiorum and B. cinerea, respectively.

Antifungal agent 14 demonstrates potent broad-spectrum antifungal activity, effectively targeting a variety of fungal strains with exceptional minimum inhibitory concentration values.

Antifungal agent 19 demonstrates potent antifungal activity (EC50 = 0.72 μM).

Antifungal agent 17 showed good antifungal activity against B. cinerea (EC50: 2.86 μg mL).

Antifungal agent 13 demonstrates significant antifungal activity against Sclerotinia sclerotiorum, achieving an EC50 of 1.25 mg L.

Antifungal agent 16 has antimicrobial activity comparable to that of ciprofloxacin and has higher antifungal activity than fluconazole.

Antifungal agent 12 is a new fluconazole-like compound that exhibits good antifungal effects.